Research

Hormonal

Pharmacological inhibition of Complement C3 using AMY-101 improves healthspan, metabolic fitness, and reduces inflammaging in aged mice.

In aged mice, weekly injections of a C3 inhibitor (AMY-101) improved metabolic health and physical function. This suggests that targeting the complement system could be a viable strategy to combat age-related decline, potentially mimicking the benefits of caloric restriction.

GoodSupportsHIGH confidence
Specific small molecule-mediated systemic C3 inhibition reduced inflammaging, improved metabolic homeostasis, and enhanced healthspan of aged mice.
Manish Mishra et al. · Nature Aging · 2025

Why this rating

Strong evidence from aged mouse models with clear healthspan metrics, though human data is limited to observational proteomics.

Source

Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging

Manish Mishra et al. · Nature Aging · 2025

DOI 10.1038/s43587-026-01107-0

preprint · n=42Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →